The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis

Psoriatic Arthritis

Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis

Semin Arthritis Rheum.

Lu C, Wallace BI, Waljee AK, Fu W, Zhang Q, Liu Y

doi: 10.1016/j.semarthrit.

Rheumatoid Arthritis

Intensive therapy and remissions in rheumatoid arthritis: a systematic review

BMC Musculoskelet Disord.

Hughes CD, Scott DL, Ibrahim F; TITRATE Programme Investigators

doi: 10.1186/s12891-018-2302-5.

Rheumatoid Arthritis

Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis

Semin Arthritis Rheum.

Myasoedova E, Karmacharya P, Duarte-Garcia A, Davis JM 3rd, Murad MH, Crowson CS

doi: 10.1016/j.semarthrit.2020.03.008.

Rheumatoid ArthritisFurther Publications Rheumatology

Risk of cancer after initiation of targeted therapies in patients with rheumatoid arthritis and a prior cancer: systematic review with meta-analysis

Arthritis Care Res (Hoboken)

Wetzman A, Lukas C, Gaujoux-Viala C, Mamtani R, Barnetche T, Combe B, Morel J, Szafors P

doi: 10.1002/acr.24784

Rheumatoid Arthritis

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis

Rheumatology (Oxford).

Bechman K, Subesinghe S, Norton S, Atzeni F, Galli M, Cope AP, Winthrop KL, Galloway JB

doi: 10.1093/rheumatology/

Rheumatoid Arthritis

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis

J Clin Rheumatol.

Fiest KM, Hitchon CA, Bernstein CN, Peschken CA, Walker JR, Graff LA, Zarychanski R, Abou-Setta A, Patten SB, Sareen J, Bolton J, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

doi: 10.1097/

Rheumatoid Arthritis

Tofacitinib in Combination with Conventional DMARDs in Patients with Active Rheumatoid Arthritis: PROs from a Phase 3 Randomized Controlled Trial

Arthritis Care Res (Hoboken).

Strand V, Kremer JM, Gruben D, Krishnaswami S, Zwillich SH, Wallenstein GV

doi: 10.1002/acr.23004.

Rheumatoid ArthritisSpinal Disorders

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Arthritis Res Ther.

Vinson D, Molet-Benhamou L, Degboé Y, den Broeder A, Ibrahim F, Pontes C, Westhovens R, Závada J, Pham T, Barnetche T, Constantin A, Ruyssen-Witrand A

doi: 10.1186/s13075-020-02188-x.

COMMENTED

Rheumatoid Arthritis

Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials

Clin Rheumatol.

Kunwar S, Collins CE, Constantinescu F

doi: 10.1007/s10067-018-4199-7.

Related content

Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis

Intensive therapy and remissions in rheumatoid arthritis: a systematic review

Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis

Risk of cancer after initiation of targeted therapies in patients with rheumatoid arthritis and a prior cancer: systematic review with meta-analysis

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis

Tofacitinib in Combination with Conventional DMARDs in Patients with Active Rheumatoid Arthritis: PROs from a Phase 3 Randomized Controlled Trial

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials